| WNT Oncogenic Transcription Requires MYC Suppression of Lysosomal Activity and EPCAM Stabilization in Gastric Tumors. | WNT Oncogenic Transcription Requires MYC Suppression of Lysosomal Activity and EPCAM Stabilization in Gastric Tumors.
Mulè P, Fernandez-Perez D, Amato S, Manganaro D, Oldani P, Brandini S, Diaferia G, Cuomo A, Recordati C, Soriani C, Dondi A, Zanotti M, Rustichelli S, Bisso A, Pece S, Rodighiero S, Natoli G, Amati B, Ferrari KJ, Chiacchiera F, Pasini D. | 09/30/2024 |
| PARP-1, EpCAM, and FRalpha as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis. | PARP-1, EpCAM, and FRα as potential targets for intraoperative detection and delineation of endometriosis: a quantitative tissue expression analysis.
Belmonte B, Di Lorenzo G, Mangogna A, Bortot B, Bertolazzi G, Sammataro S, Merighi S, Martorana A, Zito G, Romano F, Giorgiutti A, Bottin C, Zanconati F, Romano A, Ricci G, Biffi S., Free PMC Article | 09/10/2024 |
| Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression. | Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression.
Panda SS, Lee CC, Geevimaan K, Chen KC, Yang SH, Shen CN, HuangFu WC, Wu HC., Free PMC Article | 07/17/2024 |
| Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8[+] T cell infiltration. | Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8(+) T cell infiltration.
Kanahori M, Shimada E, Matsumoto Y, Endo M, Fujiwara T, Nabeshima A, Hirose T, Kawaguchi K, Oyama R, Oda Y, Nakashima Y., Free PMC Article | 04/10/2024 |
| Rab11 suppresses head and neck carcinoma by regulating EGFR and EpCAM exosome secretion. | Rab11 suppresses head and neck carcinoma by regulating EGFR and EpCAM exosome secretion.
Yoshida K, Htike K, Eguchi T, Kawai H, Eain HS, Tran MT, Sogawa C, Umemori K, Ogawa T, Kanemoto H, Ono K, Nagatsuka H, Sasaki A, Ibaragi S, Okamoto K. | 03/8/2024 |
| TLR4, IgA and EpCAM Expression in Colorectal Cancer and Their Possible Association with Microbiota as a Pathogenic Factor; An Immunohistochemical and Genetic Study. | TLR4, IgA and EpCAM Expression in Colorectal Cancer and Their Possible Association with Microbiota as a Pathogenic Factor; An Immunohistochemical and Genetic Study.
Hafez FS, Shakweer MM, Sabry D, Tawfik AM, El-Beah SM, Elsheshtawy NM, Shash LS, Salama DEA, Gaballah A., Free PMC Article | 02/29/2024 |
| [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis]. | [Expression of RACK1 and EGP40 in oral squamous cell carcinoma and its correlation with clinicopathological features and prognosis].
Duan YH, Wu KL, Mei J, Zhou YY, Liu MS. | 12/6/2023 |
| Extranodal Extension and Epithelial Cell Adhesion Molecule Over-expression in Oral Squamous Cell Carcinoma. | Extranodal Extension and Epithelial Cell Adhesion Molecule Over-expression in Oral Squamous Cell Carcinoma.
Fukushima H, Naruse T, Furukawa K, Omori K, Miyoshi T, Miura KI, Otsuru M, Umeda M. | 12/1/2023 |
| Plasma-derived extracellular vesicle surface markers CD45, CD326 and CD56 correlate with the stage of osteoarthritis: a primary study of a novel and promising diagnostic tool of the disease. | Plasma-derived extracellular vesicle surface markers CD45, CD326 and CD56 correlate with the stage of osteoarthritis: a primary study of a novel and promising diagnostic tool of the disease.
Matejova J, Fecskeova LK, Slovinska L, Harvanova D, Spakova T, Bzdilova J., Free PMC Article | 11/28/2023 |
| Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1. | Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1.
Omar FA, Brown TC, Gillanders WE, Fleming TP, Smith MA, Bremner RM, Sankpal NV., Free PMC Article | 10/30/2023 |
| Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions. | Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions.
Mangla G, Bakshi P, Agarwal P, Verma K. | 10/13/2023 |
| Clinicopathologic Impact of NANOG, ZEB1, and EpCAM Biomarkers on Prognosis of Serous Ovarian Carcinoma. | Clinicopathologic Impact of NANOG, ZEB1, and EpCAM Biomarkers on Prognosis of Serous Ovarian Carcinoma.
Ibrahim HM, Abdelrahman AE, Elsebai E, Gharieb SA, Fahmy MM, Ramadan MSH, Wasfy MA, Abdullatif A., Free PMC Article | 10/5/2023 |
| The roles EpCAM plays to enhance the malignancy of gastric cancer. | The roles EpCAM plays to enhance the malignancy of gastric cancer.
Zhao X, Zhao R, Feng Y, Qiu Z, Bai X, Zhang D, Zhou Y, Fang H, Liu N, Chen L, Jia C, Yuan Y, Li X, Duan W, Nie G, Hou Y. | 08/1/2023 |
| Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer. | Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer.
Süer H, Erus S, Cesur EE, Yavuz Ö, Ağcaoğlu O, Bulutay P, Önder TT, Tanju S, Dilege Ş., Free PMC Article | 06/22/2023 |
| CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence. | CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
Gómez-Gallegos AA, Ramírez-Vidal L, Becerril-Rico J, Pérez-Islas E, Hernandez-Peralta ZJ, Toledo-Guzmán ME, García-Carrancá A, Langley E, Hernández-Guerrero A, López-Casillas F, Herrera-Goepfert R, Oñate-Ocaña LF, Ortiz-Sánchez E., Free PMC Article | 02/11/2023 |
| SNAI2 Attenuated the Stem-like Phenotype by Reducing the Expansion of EPCAM[high] Cells in Cervical Cancer Cells. | SNAI2 Attenuated the Stem-like Phenotype by Reducing the Expansion of EPCAM(high) Cells in Cervical Cancer Cells.
Liu X, Zhang N, Chen Q, Feng Q, Zhang Y, Wang Z, Yue X, Li H, Cui N., Free PMC Article | 01/28/2023 |
| Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation. | Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation.
Hwang HS, Yoo JE, Han DH, Choi JS, Lee JG, Joo DJ, Kim MS, Kim SI, Choi GH, Park YN., Free PMC Article | 05/21/2022 |
| EpCAM and microvascular obstruction in patients with STEMI: a cardiac magnetic resonance study. | EpCAM and microvascular obstruction in patients with STEMI: a cardiac magnetic resonance study.
Ríos-Navarro C, Gavara J, Núñez J, Revuelta-López E, Monmeneu JV, López-Lereu MP, de Dios E, Pérez-Solé N, Vila JM, Oltra R, Chorro FJ, Bayés-Genís A, Bodi V. | 05/21/2022 |
| EpCAM (MOC-31) - immunohistochemical expression in papillary thyroid carcinoma and non invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). | EpCAM (MOC-31) - immunohistochemical expression in papillary thyroid carcinoma and non invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Ben Rejeb S, Beltaifa D, Ghozzi A, Bellil K, Turki S., Free PMC Article | 04/9/2022 |
| BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma. | BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H, Nio K, Yamashita T, Okada H, Li R, Suda T, Li Y, Doan PTB, Seki A, Nakagawa H, Toyama T, Terashima T, Iida N, Shimakami T, Takatori H, Kawaguchi K, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S., Free PMC Article | 04/2/2022 |
| Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses. | Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses.
Yang Y, McCloskey JE, Yang H, Puc J, Alcaina Y, Vedvyas Y, Gomez Gallegos AA, Ortiz-Sánchez E, de Stanchina E, Min IM, von Hofe E, Jin MM., Free PMC Article | 03/12/2022 |
| Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients. | Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
AbdelMageed M, Ismail HTH, Olsson L, Lindmark G, Hammarström ML, Hammarström S, Sitohy B., Free PMC Article | 02/5/2022 |
| Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer. | Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer.
Kalantari E, Taheri T, Fata S, Abolhasani M, Mehrazma M, Madjd Z, Asgari M., Free PMC Article | 01/22/2022 |
| Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas. | Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.
Schinke H, Heider T, Herkommer T, Simon F, Blancke Soares A, Kranz G, Samaga D, Dajka L, Feuchtinger A, Walch A, Valeanu L, Walz C, Kirchner T, Canis M, Baumeister P, Belka C, Maihöfer C, Marschner S, Pflugradt U, Ganswindt U, Hess J, Zitzelsberger H, Gires O., Free PMC Article | 01/15/2022 |
| Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition. | Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
Shi RZ, He YF, Wen J, Niu YN, Gao Y, Liu LH, Zhang XP, Wang Y, Zhang XL, Zhang HF, Chen M, Hu XL. | 12/25/2021 |